-
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Average Recommendation of "Moderate Buy" by Analysts
来源: Buzz FX / 15 11月 2024 03:36:18 America/Chicago
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat November 15, 2024 Share Link copied to clipboard. Shares of Viridian Therapeutics, Inc.
Read more...